Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paesmans

Showing results (121-130 of 187) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
British Journal of Cancer|June 21, 2006
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsC Mascaux, B Martin, M Paesmans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Revue Des Maladies Respiratoires|December 11, 2002
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]P Delmotte, B Martin, M Paesmans, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
International Journal of Oncology|October 20, 2004
Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancerV Durbecq, C Desmed, M Paesmans, et al.
The European Respiratory Journal|November 5, 2002
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisA P Meert, B Martin, P Delmotte, et al.
International Journal of Oncology|May 10, 2011
A phase-ii study testing a combination chemotherapy with epirubicin and vindesine as 2nd line treatment for patients with advanced non-small-cell lung-cancerJ Sculier, G Bureau, J Thiriaux, et al.
British Journal of Cancer|April 25, 2007
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patientsE de Azambuja, F Cardoso, G de Castro, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2021
Risk factors for imminent fractures: a substudy of the FRISBEE cohortL Iconaru, M Moreau, F Baleanu, et al.
Pageof 19

Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
British Journal of Cancer|June 21, 2006
Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival resultsC Mascaux, B Martin, M Paesmans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Revue Des Maladies Respiratoires|December 11, 2002
[VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis]P Delmotte, B Martin, M Paesmans, et al.
Critical Reviews in Oncology/Hematology|March 4, 2008
A significant proportion of elderly patients develop hormone-dependant "luminal-B" tumours associated with aggressive characteristicsV Durbecq, L Ameye, I Veys, et al.
International Journal of Oncology|October 20, 2004
Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancerV Durbecq, C Desmed, M Paesmans, et al.
The European Respiratory Journal|November 5, 2002
The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysisA P Meert, B Martin, P Delmotte, et al.
International Journal of Oncology|May 10, 2011
A phase-ii study testing a combination chemotherapy with epirubicin and vindesine as 2nd line treatment for patients with advanced non-small-cell lung-cancerJ Sculier, G Bureau, J Thiriaux, et al.
British Journal of Cancer|April 25, 2007
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patientsE de Azambuja, F Cardoso, G de Castro, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 7, 2021
Risk factors for imminent fractures: a substudy of the FRISBEE cohortL Iconaru, M Moreau, F Baleanu, et al.
Pageof 19